<!--
Filename: 	Liver.md
Project: 	/Users/shume/Developer/mnemosyne/docs/MMB/docs/b_Hepa
Author: 	shumez <https://github.com/shumez>
Created: 	2019-04-03 17:17:3
Modified: 	2019-09-01 17:48:13
-----
Copyright (c) 2019 shumez
-->

# Liver

## Viral Hepetitis

<!-- <h6 id='viral_hepetitis-def'>Definition</h6> -->
<!-- <h6 id='viral_hepetitis-eti'>Etiology</h6> -->
<!-- <h6 id='viral_hepetitis-epi'>Epidemiology</h6> -->
<h6 id='viral_hepetitis-cls'>Classification</h6>

<table>
	<thead>
		<tr>
			<th width="10%"></th>
			<th width="18%">HAV</th>
			<th width="18%">HBV</th>
			<th width="18%">HCV</th>
			<th width="18%">HDV</th>
			<th width="18%">HEV</th>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th>核酸</th>
			<td>RNA</td>
			<td><u>DNA</u></td>
			<td>RNA</td>
			<td>RNA</td>
			<td>RNA</td>
		</tr>
		<tr>
			<th>主な感染様式</th>
			<td>経口</td>
			<td>血液，性交</td>
			<td>血液</td>
			<td>血液</td>
			<td>経口</td>
		</tr>
		<tr>
			<th>急性肝炎<br>
				での占有率（％）</th>
			<td align='right'><u>40-50%</u></td>
			<td align='right'>20-30%</td>
			<td align='right'>15%</td>
			<td>極めてまれ</td>
			<td>まれ</td>
		</tr>
		<tr>
			<th>慢性肝炎<br>
				での占有率（％）</th>
			<td align='right'>0%</td>
			<td align='right'>20%</td>
			<td align='right'><u>70%</u></td>
			<td>極めてまれ</td>
			<td align='right'>0%</td>
		</tr>
		<tr>
			<th>肝硬変 / 肝細胞癌<br>
				での占有率（％）</th>
			<td align='right'>0%</td>
			<td align='right'>15%</td>
			<td align='right'><u>80%</u></td>
			<td>極めてまれ</td>
			<td align='right'>0%</td>
		</tr>
		<tr>
			<th>診断</th>
			<td>
				<ul>
					<li>IgM型HA Ab</li>
				</ul>
			</td>
			<td>
				<ul>
					<li>HBs Ag</li>
					<li>IgM HBc Ab</li>
					<li>HBV-DNA</li>
				</ul>
			</td>
			<td>
				<ul>
					<li>HCV-RNA</li>
					<li>HCV Ab</li>
				</ul>
			</td>
			<td>
				<ul>
					<li>HDV Ab</li>
				</ul>
			</td>
			<td>
				<ul>
					<li>HEV Ab</li>
				</ul>
			</td>
		</tr>
		<tr>
			<th>予防</th>
			<td>
				<ul>
					<li><u>ワクチン</u></li>
				</ul>
			</td>
			<td>
				<ul>
					<li><u>ワクチン</u></li>
					<li>HBIg</li>
				</ul>
			</td>
			<td align='center'>(–)</td>
			<td>
				<ul>
					<li>HBワクチン</li>
				</ul>
			</td>
			<td align='center'>(–)</td>
		</tr>
	</tbody>
</table>

<!-- <h6 id='viral_hepetitis-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='viral_hepetitis-cmp'>Complication</h6> -->
<!-- <h6 id='viral_hepetitis-ex'>Examination</h6> -->
<!-- <h6 id='viral_hepetitis-dx'>Diagnosis</h6> -->
<!-- <h6 id='viral_hepetitis-tx'>Treatment</h6> -->
<!-- <h6 id='viral_hepetitis-prg'>Prognosis</h6> -->
<!-- <h6 id='viral_hepetitis-app'>Appendix</h6> -->


## HA

<!-- <h6 id='ha-def'>Definition</h6> -->
<!-- <h6 id='ha-eti'>Etiology</h6> -->
<!-- <h6 id='ha-epi'>Epidemiology</h6> -->
<!-- <h6 id='ha-cls'>Classification</h6> -->
<h6 id='ha-sx'>Sign and Symptom</h6>

- 発熱, 全身倦怠感

<!-- <h6 id='ha-cmp'>Complication</h6> -->
<h6 id='ha-ex'>Examination</h6>

- IgM HA-Ab

<h6 id='ha-dx'>Diagnosis</h6>

![](https://raw.githubusercontent.com/shumez/mnemosyne/master/docs/MMB/docs/img/b_Hepa/ha.jpg)

<!-- <h6 id='ha-tx'>Treatment</h6> -->
<!-- <h6 id='ha-prg'>Prognosis</h6> -->
<h6 id='ha-app'>Appendix</h6>

- Vaccine
	- HAV
	- HBV


## HE

<!-- <h6 id='he-def'>Definition</h6> -->
<h6 id='he-eti'>Etiology</h6>

- 生肉
	- イノシシ ⟹ E

<!-- <h6 id='he-epi'>Epidemiology</h6> -->
<!-- <h6 id='he-cls'>Classification</h6> -->
<h6 id='he-sx'>Sign and Symptom</h6>

- 妊娠後期: 10-20% 重症化 / 劇症化

<!-- <h6 id='he-cmp'>Complication</h6> -->
<!-- <h6 id='he-ex'>Examination</h6> -->
<!-- <h6 id='he-dx'>Diagnosis</h6> -->
<!-- <h6 id='he-tx'>Treatment</h6> -->
<!-- <h6 id='he-prg'>Prognosis</h6> -->
<!-- <h6 id='he-app'>Appendix</h6> -->


## HB

<!-- <h6 id='hb-def'>Definition</h6> -->
<h6 id='hb-eti'>Etiology</h6>

- DNA virus

<h6 id='hb-epi'>Epidemiology</h6>

- **劇症肝炎 #1**

<!-- <h6 id='hb-cls'>Classification</h6> -->
<h6 id='hb-sx'>Sign and Symptom</h6>

持続感染
![](https://raw.githubusercontent.com/shumez/mnemosyne/master/docs/MMB/docs/img/b_Hepa/hb_persistent.jpg)

一過性感染
![](https://raw.githubusercontent.com/shumez/mnemosyne/master/docs/MMB/docs/img/b_Hepa/hb_transient.jpg)

<!-- <h6 id='hb-cmp'>Complication</h6> -->
<h6 id='hb-ex'>Examination</h6>

![](https://qb.medilink-study.com/images/93F016_bas_b_010.jpg)

- IgM HBc Ab:
	- 急性肝炎
	- 慢性肝炎急性増悪
- IgG HBc Ab
	- 慢性
- HBe Ab
	- セロコンバージョン


<table>
	<tbody>
		<tr>
			<th width="10%" rowspan="2">Ag</th>
			<td width="18%">HBs</td>
			<td width="18%">HBe</td>
			<td width="18%"></td>
			<td width="18%"></td>
			<td width="18%">HBc</td>
		</tr>
		<tr>
			<td>感染状態</td>
			<td>活動期</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<th rowspan="2">Ab</th>
			<td>IgM-HBc</td>
			<td></td>
			<td>HBe</td>
			<td>IgG-HBc</td>
			<td>HBs</td>
		</tr>
		<tr>
			<td>&uarr;&uarr;&uarr;: 発症早期<br>
				&uarr;: <u>慢性肝炎の急性増悪</u></td>
			<td></td>
			<td>回復期</td>
			<td>発症後期-既往<br>
				&uarr;: 慢性肝炎の急性増悪</td>
			<td>既往 (治癒)</td>
		</tr>
	</tbody>
</table>

- **seroconversion**:  
	- Agが陰性化, Abが陽性化する
	- HBeAg(–) &rarr; HBeAb(+)
- **seronegative**:
	- HBAg (s,e) 陰性化
	- HBAb 陰性でとどまっている


<h6 id='hb-dx'>Diagnosis</h6>

- ≤ 1mo の血中HBs Ag
- ペア血清による &uarr;HBc Ab
- 発症早期 血中IgM-HBc Ab

<h6 id='hb-tx'>Treatment</h6>

- エンテカビル
- ラミブジン

- vaccine がある  
	cf.
	- HAV
	- HBV

<!-- <h6 id='hb-prg'>Prognosis</h6> -->
<!-- <h6 id='hb-app'>Appendix</h6> -->


### *de novo* HB

<h6 id='de_novo_hb-def'>Definition</h6>

- HBV既往感染者で
	- HBs Ag(–)
	- HBc Ab(+) (IgG)
	- HBs Ab(+)

<!-- <h6 id='de_novo_hb-eti'>Etiology</h6> -->
<!-- <h6 id='de_novo_hb-epi'>Epidemiology</h6> -->
<!-- <h6 id='de_novo_hb-cls'>Classification</h6> -->
<!-- <h6 id='de_novo_hb-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='de_novo_hb-cmp'>Complication</h6> -->
<h6 id='de_novo_hb-ex'>Examination</h6>

- HBs抗原 再活性化

<!-- <h6 id='de_novo_hb-dx'>Diagnosis</h6> -->
<!-- <h6 id='de_novo_hb-tx'>Treatment</h6> -->
<h6 id='de_novo_hb-prg'>Prognosis</h6>

- 予後不良

<!-- <h6 id='de_novo_hb-app'>Appendix</h6> -->


### Gianotti

<h6 id='gianotti-def'>Definition</h6>

- HB急性肝炎
- 乳幼児

<!-- <h6 id='gianotti-eti'>Etiology</h6> -->
<!-- <h6 id='gianotti-epi'>Epidemiology</h6> -->
<!-- <h6 id='gianotti-cls'>Classification</h6> -->
<!-- <h6 id='gianotti-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='gianotti-cmp'>Complication</h6> -->
<!-- <h6 id='gianotti-ex'>Examination</h6> -->
<!-- <h6 id='gianotti-dx'>Diagnosis</h6> -->
<!-- <h6 id='gianotti-tx'>Treatment</h6> -->
<!-- <h6 id='gianotti-prg'>Prognosis</h6> -->
<!-- <h6 id='gianotti-app'>Appendix</h6> -->


## HC

<!-- <h6 id='hc-def'>Definition</h6> -->
<!-- <h6 id='hc-eti'>Etiology</h6> -->
<h6 id='hc-epi'>Epidemiology</h6>

<table>
	<thead>
		<tr>
			<th colspan="2">#1</th>
		</tr>
	</thead>
	<tbody>
		<tr>
			<td><u>C</u>irrhosis</td>
			<td>肝硬変</td>
		</tr>
		<tr>
			<td><u>C</u>arcinoma</td>
			<td>癌化</td>
		</tr>
		<tr>
			<td><u>C</u>hronic</td>
			<td>慢性化</td>
		</tr>
	</tbody>
</table>

<!-- <h6 id='hc-cls'>Classification</h6> -->
<!-- <h6 id='hc-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='hc-cmp'>Complication</h6> -->
<!-- <h6 id='hc-ex'>Examination</h6> -->
<!-- <h6 id='hc-dx'>Diagnosis</h6> -->
<h6 id='hc-tx'>Treatment</h6>

- DAAs Direct Acting Antivirals (IFN free)
- IFN base
　　
　　
- genotype 1
	- エルバスビル + グラゾプレビル
	- ソホスブビル + レジパスビル
	- オムビタスビル + パリタプレビル
- genotype 2
	- ソホスブビル + リバビリン
	- オムビタスビル + パリタプレビル　+ リトナビル + リバビリン

IFN AE:

- インフルエンザ様
- うつ病
- 間質性肺炎
- 出血傾向 ⇐ ↓Plt
- 眼底出血

<!-- <h6 id='hc-prg'>Prognosis</h6> -->
<!-- <h6 id='hc-app'>Appendix</h6> -->


## HD

Hepatitis D

<!-- <h6 id='hd-def'>Definition</h6> -->
<!-- <h6 id='hd-eti'>Etiology</h6> -->
<!-- <h6 id='hd-epi'>Epidemiology</h6> -->
<!-- <h6 id='hd-cls'>Classification</h6> -->
<!-- <h6 id='hd-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='hd-cmp'>Complication</h6> -->
<!-- <h6 id='hd-ex'>Examination</h6> -->
<!-- <h6 id='hd-dx'>Diagnosis</h6> -->
<!-- <h6 id='hd-tx'>Treatment</h6> -->
<!-- <h6 id='hd-prg'>Prognosis</h6> -->
<!-- <h6 id='hd-app'>Appendix</h6> -->


## AVH

Acute Viral Hepatitis

<!-- <h6 id='avh-def'>Definition</h6> -->
<!-- <h6 id='avh-eti'>Etiology</h6> -->
<!-- <h6 id='avh-epi'>Epidemiology</h6> -->
<!-- <h6 id='avh-cls'>Classification</h6> -->
<!-- <h6 id='avh-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='avh-cmp'>Complication</h6> -->
<h6 id='avh-ex'>Examination</h6>

- &uarr;AST &uarr;ALT
	- 極期 AST > ALT
	- 回復期 AST < ALT
- **PT** ≤ 40% &xrArr; 重症

<!-- <h6 id='avh-dx'>Diagnosis</h6> -->
<!-- <h6 id='avh-tx'>Treatment</h6> -->
<!-- <h6 id='avh-prg'>Prognosis</h6> -->
<!-- <h6 id='avh-app'>Appendix</h6> -->


## CVH

Chronic Viral Hepatitis

<!-- <h6 id='cvh-def'>Definition</h6> -->
<h6 id='cvh-eti'>Etiology</h6>

1. HCV 80%
2. HBV 20%

<!-- <h6 id='cvh-epi'>Epidemiology</h6> -->
<!-- <h6 id='cvh-cls'>Classification</h6> -->
<!-- <h6 id='cvh-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='cvh-cmp'>Complication</h6> -->
<!-- <h6 id='cvh-ex'>Examination</h6> -->
<!-- <h6 id='cvh-dx'>Diagnosis</h6> -->
<!-- <h6 id='cvh-tx'>Treatment</h6> -->
<!-- <h6 id='cvh-prg'>Prognosis</h6> -->
<!-- <h6 id='cvh-app'>Appendix</h6> -->


## DILD

Drug-induced Liver Disease 薬剤性肝障害

<!-- <h6 id='dild-def'>Definition</h6> -->
<!-- <h6 id='dild-eti'>Etiology</h6> -->
<!-- <h6 id='dild-epi'>Epidemiology</h6> -->
<h6 id='dild-cls'>Classification</h6>

<table>
	<thead>
		<tr>
			<th width=20%></th>
			<th width=40%>肝細胞障害</th>
			<th width=40%>胆汁うっ滞</th>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th>原因</th>
			<td>
				<ul>
					<li><u>Acetaminophen<!-- アセトアミノフェン --></u></li>
					<li>ハロセン</li>
					<li>四塩化炭素</li>
					<li><u>INH</u></li>
					<li>α-メチルドパ</li>
					<li><u>Tetracycline<!-- テトラサイクリン --></u></li>
					<li><u>RFP</u></li>
					<li>MTX<!-- メトトレキサート --></li>
					<li><u>Azathioprine<!-- アザチオプリン --></u></li>
					<!-- <li>P</li>
					<li>ジフェニルヒダトイン</li>
					<li>ケトコナゾール</li>
					<li><u>クロロホルム（CHCl3）</u></li>
					<li>Vit. A</li>
					<li>バルプロ酸ニトロフラントイン</li>
					<li>アスピリン</li> -->
				</ul>
			</td>
			<td>
				<ul>
					<li><u>クロルプロマジン</u></li>
					<li>エリスロマイシン</li>
					<li><u>蛋白同化ホルモン</u><br>
						(<u>メチルテストステロン</u>)</li>
					<li>経口避妊薬</li>
					<li><u>PTU<!-- プロピルチオウラシル --></u></li>
					<!-- <li>サルファ薬</li>
					<li>RFP</li>
					<li>テオプロミン</li>
					<li>アジマリン</li>
					<li>セフェム系</li>
					<li>ペニシリン系</li>
					<li>シクロスポリン</li>
					<li>アセトアミノフェン<br>
						(肝細胞障害が主)</li> -->
				</ul>
			</td>
		</tr>
		<tr>
			<th>逸脱酵素</th>
			<td align='center'>&uarr;&uarr;&uarr;</td>
			<td align='center'>&uarr;</td>
		</tr>
		<tr>
			<th>胆道系酵素</th>
			<td align='center'>&uarr;</td>
			<td align='center'>&uarr;&uarr;&uarr;</td>
		</tr>
		<tr>
			<th>黄疸</th>
			<td align='center'>&uarr;</td>
			<td align='center'>&uarr;&uarr;&uarr;</td>
		</tr>
		<tr>
			<th>薬剤中止後</th>
			<td>速やかに改善</td>
			<td>遅延</td>
		</tr>
	</tbody>
</table>

<!-- <h6 id='dild-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='dild-cmp'>Complication</h6> -->
<!-- <h6 id='dild-ex'>Examination</h6> -->
<!-- <h6 id='dild-dx'>Diagnosis</h6> -->
<!-- <h6 id='dild-tx'>Treatment</h6> -->
<!-- <h6 id='dild-prg'>Prognosis</h6> -->
<!-- <h6 id='dild-app'>Appendix</h6> -->

## FH / ALF

Fulminant Hepatitis 劇症肝炎 / Acute Liver Failure 急性肝不全

<h6 id='fh_alf-def'>Definition</h6>

- 初発症状出現から ≤ 8w (56d)に, PT ≤ 40% / INR ≥ 1.5

<h6 id='fh_alf-eti'>Etiology</h6>

1. HBV

<!-- <h6 id='fh_alf-epi'>Epidemiology</h6> -->
<!-- <h6 id='fh_alf-cls'>Classification</h6> -->
<h6 id='fh_alf-sx'>Sign and Symptom</h6>

- **腎不全** / 出血傾向 / 腹水
- **肝萎縮** / 肝濁音界縮小
- **意識障害** (**↑頭蓋内圧**)

<!-- <h6 id='fh_alf-cmp'>Complication</h6> -->
<h6 id='fh_alf-ex'>Examination</h6>

- PT ≤ 40%
- L/D
	- ↓Chol / ↓Alb / ↓ChE
	- ↑Bil / ↑HN3 / ↑AAA

<!-- <h6 id='fh_alf-dx'>Diagnosis</h6> -->
<!-- <h6 id='fh_alf-tx'>Treatment</h6> -->
<h6 id='fh_alf-prg'>Prognosis</h6>

- 亜急性型 予後不良
	- 急性: 50%
	- 亜急性: 10%

<!-- <h6 id='fh_alf-app'>Appendix</h6> -->


### LOHF

Late Onset Hepatic Failure 遅発性肝不全

<!-- <h6 id='lohf-def'>Definition</h6> -->
<!-- <h6 id='lohf-eti'>Etiology</h6> -->
<!-- <h6 id='lohf-epi'>Epidemiology</h6> -->
<!-- <h6 id='lohf-cls'>Classification</h6> -->
<!-- <h6 id='lohf-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='lohf-cmp'>Complication</h6> -->
<!-- <h6 id='lohf-ex'>Examination</h6> -->
<!-- <h6 id='lohf-dx'>Diagnosis</h6> -->
<!-- <h6 id='lohf-tx'>Treatment</h6> -->
<!-- <h6 id='lohf-prg'>Prognosis</h6> -->
<!-- <h6 id='lohf-app'>Appendix</h6> -->


### Acute on Chronic

<!-- <h6 id='acute_on_chronic-def'>Definition</h6> -->
<!-- <h6 id='acute_on_chronic-eti'>Etiology</h6> -->
<!-- <h6 id='acute_on_chronic-epi'>Epidemiology</h6> -->
<!-- <h6 id='acute_on_chronic-cls'>Classification</h6> -->
<!-- <h6 id='acute_on_chronic-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='acute_on_chronic-cmp'>Complication</h6> -->
<!-- <h6 id='acute_on_chronic-ex'>Examination</h6> -->
<!-- <h6 id='acute_on_chronic-dx'>Diagnosis</h6> -->
<!-- <h6 id='acute_on_chronic-tx'>Treatment</h6> -->
<!-- <h6 id='acute_on_chronic-prg'>Prognosis</h6> -->
<!-- <h6 id='acute_on_chronic-app'>Appendix</h6> -->


## FL

Fatty Liver 脂肪肝

<!-- <h6 id='fl-def'>Definition</h6> -->
<h6 id='fl-eti'>Etiology</h6>

↓insulin感受性  
Adipocyte → レジスチン

<h6 id='fl-epi'>Epidemiology</h6>

- DM合併

<h6 id='fl-cls'>Classification</h6>

- 脂肪肝
	- アルコール性
	- NAFLD 肝疾患
		- NAFL 非アルコール性脂肪肝
		- NASH 非アルコール性脂肪肝炎

<!-- <h6 id='fl-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='fl-cmp'>Complication</h6> -->
<h6 id='fl-ex'>Examination</h6>

![](https://qb.medilink-study.com/images/102D014_sup_b_010.jpg "肝障害 / AST/ALT")

- L/D
	- **↑ALT優位**: 非アルコール性
	- ↑AST優位: アルコール性

![](https://qb.medilink-study.com/images/99G027.jpg)


- U/S
	- 肝腎コントラスト (Bright liver)

<!-- <h6 id='fl-dx'>Diagnosis</h6> -->
<!-- <h6 id='fl-tx'>Treatment</h6> -->
<!-- <h6 id='fl-prg'>Prognosis</h6> -->
<!-- <h6 id='fl-app'>Appendix</h6> -->


## NAFLD

Non Alcoholic Fatty Liver Disease 非アルコール性脂肪性肝疾患

<!-- <h6 id='nafld-def'>Definition</h6> -->
<!-- <h6 id='nafld-eti'>Etiology</h6> -->
<!-- <h6 id='nafld-epi'>Epidemiology</h6> -->
<!-- <h6 id='nafld-cls'>Classification</h6> -->
<!-- <h6 id='nafld-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='nafld-cmp'>Complication</h6> -->
<!-- <h6 id='nafld-ex'>Examination</h6> -->
<!-- <h6 id='nafld-dx'>Diagnosis</h6> -->
<!-- <h6 id='nafld-tx'>Treatment</h6> -->
<!-- <h6 id='nafld-prg'>Prognosis</h6> -->
<!-- <h6 id='nafld-app'>Appendix</h6> -->


### NASH

Non-Alcoholic SteatoHepatitis 非アルコール性脂肪性肝炎

<!-- <h6 id='nash-def'>Definition</h6> -->
<!-- <h6 id='nash-eti'>Etiology</h6> -->
<!-- <h6 id='nash-epi'>Epidemiology</h6> -->
<!-- <h6 id='nash-cls'>Classification</h6> -->
<!-- <h6 id='nash-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='nash-cmp'>Complication</h6> -->
<h6 id='nash-ex'>Examination</h6>

- 風船様膨化

<!-- <h6 id='nash-dx'>Diagnosis</h6> -->
<!-- <h6 id='nash-tx'>Treatment</h6> -->
<!-- <h6 id='nash-prg'>Prognosis</h6> -->
<!-- <h6 id='nash-app'>Appendix</h6> -->


## ALD 

Alcoholic Liver Disease アルコール性肝障害

<!-- <h6 id='ald-def'>Definition</h6> -->
<!-- <h6 id='ald-eti'>Etiology</h6> -->
<!-- <h6 id='ald-epi'>Epidemiology</h6> -->
<!-- <h6 id='ald-cls'>Classification</h6> -->
<!-- <h6 id='ald-sx'>Sign and Symptom</h6> -->
<h6 id='ald-cmp'>Complication</h6>

- アルコール性心筋症
- Wernicke

<h6 id='ald-ex'>Examination</h6>

![](https://qb.medilink-study.com/images/101G028.jpg)

- Patho
	- 肝細胞の風船様変化 (Balooning)  
		cf. 急性肝炎 風船細胞 (baloon cell)
	- アルコール硝子体 (**Mallory body**)
	- **Neut浸潤**
	- 脂肪変性
	- **肝細胞周囲性線維化** (Pericellular fibrosis)

<!-- <h6 id='ald-dx'>Diagnosis</h6> -->
<!-- <h6 id='ald-tx'>Treatment</h6> -->
<!-- <h6 id='ald-prg'>Prognosis</h6> -->
<h6 id='ald-app'>Appendix</h6>

- SAH Severe alcoholic hepatitis (重症アルコール性肝炎)
- Zieve synd


## LC

Liver Cirrhosis

<!-- <h6 id='lc-def'>Definition</h6> -->
<h6 id='lc-eti'>Etiology</h6>

* &darr;Alb  
	&rArr; &darr;循環血漿量  
	&rArr; &darr;腎血流量  
	&rArr; &uarr;RAAs, &uarr;ADH  
	&rArr; &uarr;Na &darr;K &darr;水排泄

<!-- <h6 id='lc-epi'>Epidemiology</h6> -->
<h6 id='lc-cls'>Classification</h6>

- 機能的:
	- 代償期
	- 非代償期
		- 漏出性腹水
		- 出血傾向

<!-- <h6 id='lc-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='lc-cmp'>Complication</h6> -->
<h6 id='lc-ex'>Examination</h6>

- PEx
	- - ≥ II 羽ばたき振戦

![](https://shumez.github.io/mnemosyne/Fornix/b_Hepa/fig/flying_bat.jpeg)

- CT
	- Flying bat pattern

<!-- <h6 id='lc-dx'>Diagnosis</h6> -->
<h6 id='lc-tx'>Treatment</h6>

- 腹水・浮腫の治療:
	- 塩分制限
	- 水分除去
		- 利尿薬
		- 腹腔穿刺
	- アルブミン補充
- 肝性脳症:
	- 低蛋白食
	- 腸内細菌を整える
		- 下剤
		- 非吸収性抗菌薬  
			(アンモニアの上昇を抑えるため)
	- 消化管出血

1. 抗アルドステロン薬 
2. ループ利尿薬


- トルバプタン (V~2~ ant)

<!-- <h6 id='lc-prg'>Prognosis</h6> -->
<h6 id='lc-app'>Appendix</h6>

SBP 特発性細菌性腹膜炎

- Etiology
	- GNB
		- E. coli
- Symptom
	- 発熱/悪寒
	- 腹痛
	- 下痢
	- 脳症
	- 腎不全


## AIH



<!-- <h6 id='aih-def'>Definition</h6> -->
<!-- <h6 id='aih-eti'>Etiology</h6> -->
<!-- <h6 id='aih-epi'>Epidemiology</h6> -->
<!-- <h6 id='aih-cls'>Classification</h6> -->
<!-- <h6 id='aih-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='aih-cmp'>Complication</h6> -->
<h6 id='aih-ex'>Examination</h6>

- 抗平滑筋Ab

<h6 id='aih-dx'>Diagnosis</h6>

AIH / PBC / PSC

<table>
	<tbody>
		<tr>
			<th>AIH</th>
			<td>
				<ul>
					<li>&uarr;IgG</li>
					<li>抗核抗体</li>
					<li>抗平滑筋抗体</li>
				</ul>
			</td>
		</tr>
		<tr>
			<th>PBC</th>
			<td>
				<ul>
					<li>&uarr;IgM</li>
					<li>抗ミトコンドリア抗体</li>
				</ul>
			</td>
		</tr>
		<tr>
			<th>PSC</th>
			<td>
				<ul>
					<li>P-ANCA</li>
				</ul>
			</td>
		</tr>
	</tbody>
</table>

AIH / PBC

<table>
	<thead>
		<tr>
			<th width="20%"></th>
			<th width="40%">AIH</th>
			<th width="40%">PBC</th>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th>Epid</th>
			<td>中年 F<br>
				HLA-DR4(+)</td>
			<td>中年 F<br>
				HLA-DR8(+)</td>
		</tr>
		<tr>
			<th>AutoAb</th>
			<td>
				<ul>
					<li>抗核抗体</li>
					<li>抗平滑筋</li>
				</ul>
			</td>
			<td>
				<ul>
					<li>AMA</li>
				</ul>
			</td>
		</tr>
		<tr>
			<th>Ig</th>
			<td>IgG</td>
			<td>IgM</td>
		</tr>
		<tr>
			<th>Comp</th>
			<td>
				<ul>
					<li>自己免疫疾患</li>
				</ul>
			</td>
			<td>
				<ul>
					<li>自己免疫疾患</li>
					<li>骨粗鬆症</li>
					<li>脂質異常症</li>
				</ul>
			</td>
		</tr>
		<tr>
			<th>Rx</th>
			<td>
				<ul>
					<li>ステロイド</li>
				</ul>
			</td>
			<td>
				<ul>
					<li>UDCA</li>
					<li>肝移植</li>
				</ul>
				C/I ステロイド
			</td>
		</tr>
	</tbody>
</table>

<h6 id='aih-tx'>Treatment</h6>

- PSL

<!-- <h6 id='aih-prg'>Prognosis</h6> -->
<!-- <h6 id='aih-app'>Appendix</h6> -->


## PBC

Primary Billary Cholangitis / Cirrhosis

<!-- <h6 id='pbc-def'>Definition</h6> -->
<!-- <h6 id='pbc-eti'>Etiology</h6> -->
<!-- <h6 id='pbc-epi'>Epidemiology</h6> -->
<!-- <h6 id='pbc-cls'>Classification</h6> -->
<h6 id='pbc-sx'>Sign and Symptom</h6>

- 皮膚掻痒感
- 黄色腫

<h6 id='pbc-cmp'>Complication</h6>

- 自己免疫
	- Sjögren
	- 慢性甲状腺炎
	- RA
	- CREST
- 門脈圧亢進
	- 食道静脈瘤
- 骨軟化症 / 骨粗鬆症
- 脂質異常症
	- 皮膚黄色腫

<h6 id='pbc-ex'>Examination</h6>

- Ig
	- 抗ミトコンドリアAb (AMA)
	- **↑IgM**  
		A**M**A / Ig**M**
- 病理:
	- CNSDC 破壊性胆管炎 **胆管消失**
	- 続発性PBC:
		- **Glisson sheath fibrosis**
		- **胆管の拡張**
![](https://qb.medilink-study.com/images/96C010_ref_b_010.jpg)
	
	- 胆管上皮の重層化
	- 胆管基底膜の破壊
	- 胆管周囲のリンパ球浸潤
	- 慢性非化膿性破壊性胆管炎 (CNSDC)

<!-- <h6 id='pbc-dx'>Diagnosis</h6> -->
<h6 id='pbc-tx'>Treatment</h6>

- ウルソデオキシコール酸
- 肝移植

C/I

- ステロイド  
	骨粗鬆症 増悪

<h6 id='pbc-prg'>Prognosis</h6>

- 胆道癌にはならない

<h6 id='pbc-app'>Appendix</h6>

- AIH-PBC overlap syndrome


## HCC

<!-- <h6 id='hcc-def'>Definition</h6> -->
<h6 id='hcc-eti'>Etiology</h6>

- **アフラトキシン** (ピーナッツのカビが産生)
- OC

<!-- <h6 id='hcc-epi'>Epidemiology</h6> -->
<!-- <h6 id='hcc-cls'>Classification</h6> -->
<!-- <h6 id='hcc-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='hcc-cmp'>Complication</h6> -->
<h6 id='hcc-ex'>Examination</h6>

- AFP
- 肝内転移
- Hyper-vascular
- US
	- **モザイクパターン**
	- **辺縁低エコー** (**halo**)

<!-- <h6 id='hcc-dx'>Diagnosis</h6> -->
<h6 id='hcc-tx'>Treatment</h6>

![](https://shumez.github.io/mnemosyne/Fornix/b_Hepa/fig/HCC_treatment.jpeg)

- ICG < 30
- ICG ≥ 30
	- ≤ 3cm ⟹ RFA
	- &gt; 3cm ⟹ TACE

![](https://qb.medilink-study.com/images/103D031_bas_b_010.jpg)

肝切除

- 肝癌 単発, 同一区域
- 症状(–)
	- 黄疸(–)
	- 腹水(–)
	- 肝性脳症(–)
- ICG ≤ 30%

TACE / TAE

- IND
	- 門脈本幹に閉塞(-)
	- T-Bil ≤ 3が好まれる
	- 大きさ/個数は問わない
- C/I
	- 高度黄疸
	- 難治性腹水
	-門脈本幹に狭窄

<h6 id='hcc-prg'>Prognosis</h6>

- Good (HCC)  
	cf. CCC

<h6 id='hcc-app'>Appendix</h6>

HCC / 転移性肝癌

<table>
	<thead>
		<tr>
			<th></th>
			<th>超音波像</th>
			<th colspan="2">CTスキャン</th>
			<th>選択的肝動脈造影</th>
		</tr>
		<tr>
			<th></th>
			<th></th>
			<th>単純</th>
			<th>造影</th>
			<th></th>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th>肝内結石症</th>
			<td>高エコー<br>
				（acoustic shadowを伴う）</td>
			<td>HD</td>
			<td>（−）</td>
			<td>所見（−）</td>
		</tr>
		<tr>
			<th>肝細胞癌</th>
			<td>低エコー<br>
				高エコー<br>
				モザイクエコーetc．<br>
				(大きくなればhalo)</td>
			<td>LD</td>
			<td>（＋）</td>
			<td>
				<ul>
					<li>hypervascular stainは静脈相以後直ちに消える</li>
				</ul>
			</td>
		</tr>
		<tr>
			<th>転移性肝癌</th>
			<td>低エコー<br>
				高エコー<br>
				など様々．<br>
				bull’s eye</td>
			<td>LD</td>
			<td>（＋）〜（−）</td>
			<td>
				<ul>
					<li>hypovascular</li>
					<li>多発性</li>
				</ul>
			</td>
		</tr>
	</tbody>
</table>


## CCC 

<!-- <h6 id='ccc-def'>Definition</h6> -->
<!-- <h6 id='ccc-eti'>Etiology</h6> -->
<!-- <h6 id='ccc-epi'>Epidemiology</h6> -->
<!-- <h6 id='ccc-cls'>Classification</h6> -->
<!-- <h6 id='ccc-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='ccc-cmp'>Complication</h6> -->
<h6 id='ccc-ex'>Examination</h6>

- **↑CA19-9**
- リンパ節転移(++)

<!-- <h6 id='ccc-dx'>Diagnosis</h6> -->
<!-- <h6 id='ccc-tx'>Treatment</h6> -->
<h6 id='ccc-prg'>Prognosis</h6>

- 予後不良 5YSR: 20%

<!-- <h6 id='ccc-app'>Appendix</h6> -->


## Metastatic Liver Cancer

<!-- <h6 id='metastatic_liver_cancer-def'>Definition</h6> -->
<h6 id='metastatic_liver_cancer-eti'>Etiology</h6>

- 大腸癌(++)

<!-- <h6 id='metastatic_liver_cancer-epi'>Epidemiology</h6> -->
<!-- <h6 id='metastatic_liver_cancer-cls'>Classification</h6> -->
<!-- <h6 id='metastatic_liver_cancer-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='metastatic_liver_cancer-cmp'>Complication</h6> -->
<h6 id='metastatic_liver_cancer-ex'>Examination</h6>

- **Hypovascular**
- ↑CEA (大腸)

<!-- <h6 id='metastatic_liver_cancer-dx'>Diagnosis</h6> -->
<h6 id='metastatic_liver_cancer-tx'>Treatment</h6>

- 切除
	- 腫瘍少数
	- 肝外転移(-)
	- 大腸癌原発
- CCT

<!-- <h6 id='metastatic_liver_cancer-prg'>Prognosis</h6> -->
<!-- <h6 id='metastatic_liver_cancer-app'>Appendix</h6> -->


## Hemangioma

肝血管腫

<!-- <h6 id='hemangioma-def'>Definition</h6> -->
<!-- <h6 id='hemangioma-eti'>Etiology</h6> -->
<!-- <h6 id='hemangioma-epi'>Epidemiology</h6> -->
<!-- <h6 id='hemangioma-cls'>Classification</h6> -->
<!-- <h6 id='hemangioma-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='hemangioma-cmp'>Complication</h6> -->
<h6 id='hemangioma-ex'>Examination</h6>

![](https://qb.medilink-study.com/images/105A026_bas_b_010.jpg)

<!-- <h6 id='hemangioma-dx'>Diagnosis</h6> -->
<h6 id='hemangioma-tx'>Treatment</h6>

- **経過観察**

<!-- <h6 id='hemangioma-prg'>Prognosis</h6> -->
<!-- <h6 id='hemangioma-app'>Appendix</h6> -->


### Kasabach-Merrit

<!-- <h6 id='kasabach-merrit-def'>Definition</h6> -->
<!-- <h6 id='kasabach-merrit-eti'>Etiology</h6> -->
<!-- <h6 id='kasabach-merrit-epi'>Epidemiology</h6> -->
<!-- <h6 id='kasabach-merrit-cls'>Classification</h6> -->
<h6 id='kasabach-merrit-sx'>Sign and Symptom</h6>

- DIC

<!-- <h6 id='kasabach-merrit-cmp'>Complication</h6> -->
<!-- <h6 id='kasabach-merrit-ex'>Examination</h6> -->
<!-- <h6 id='kasabach-merrit-dx'>Diagnosis</h6> -->
<h6 id='kasabach-merrit-tx'>Treatment</h6>

- **ヘパリン**
- **FFP**

<!-- <h6 id='kasabach-merrit-prg'>Prognosis</h6> -->
<!-- <h6 id='kasabach-merrit-app'>Appendix</h6> -->


## Hepatoblastoma


<!-- <h6 id='hepatoblastoma-def'>Definition</h6> -->
<!-- <h6 id='hepatoblastoma-eti'>Etiology</h6> -->
<!-- <h6 id='hepatoblastoma-epi'>Epidemiology</h6> -->
<!-- <h6 id='hepatoblastoma-cls'>Classification</h6> -->
<!-- <h6 id='hepatoblastoma-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='hepatoblastoma-cmp'>Complication</h6> -->
<h6 id='hepatoblastoma-ex'>Examination</h6>

- ↑AFP

<!-- <h6 id='hepatoblastoma-dx'>Diagnosis</h6> -->
<!-- <h6 id='hepatoblastoma-tx'>Treatment</h6> -->
<!-- <h6 id='hepatoblastoma-prg'>Prognosis</h6> -->
<!-- <h6 id='hepatoblastoma-app'>Appendix</h6> -->


## Portal Hypertension

<!-- **Definition** -->
<!-- *  -->
<!-- **Etiology** -->
<!-- *  -->
<!-- **Epidemiology** -->
<!-- *  -->
**Classification**

| Lesion		|				| Dx 					|
|---------------|---------------|-----------------------|
| IVC			| Post-hepatic	| [Budd-Chiari]			|
| EHV			| Post-hepatic	| 						|
| IHV			|				| [Liver Cirrhosis]		|
| Sinusouid		| 				|						|
| IPV			|				| [IPH], [日本住血吸虫症] |
| PV / spleen	| Pre-hepatic	| [先天性門脈形成異常], [門脈血栓症]|


<!-- **Sign and Symptom** -->
<!-- *  -->
<!-- **Association** -->
<!-- *  -->
<!-- **Examination** -->
<!-- *  -->
<!-- **Diagnosis** -->
<!-- *  -->
<!-- **Treatment** -->
<!-- *  -->
<!-- **Prognosis** -->
<!-- *  -->
<!-- **Appendix** -->
<!-- *  -->

## IPH

<!-- **Definition** -->
<!-- *  -->
<!-- **Etiology** -->
<!-- *  -->

**Epidemiology**

* 中年F (40-50s) (M:F = 1:3)
<!-- **Classification** -->
<!-- *  -->
<!-- **Sign and Symptom** -->
<!-- *  -->
<!-- **Association** -->
<!-- *  -->
<!-- **Examination** -->
<!-- *  -->
<!-- **Diagnosis** -->
<!-- *  -->
<!-- **Treatment** -->
<!-- *  -->
<!-- **Prognosis** -->
<!-- *  -->
<!-- **Appendix** -->
<!-- *  -->

## EHO

**Definition**

* 肝外門脈閉塞 &rArr; 求肝性側副血行路
<!-- **Etiology** -->
<!-- *  -->
<!-- **Epidemiology** -->
<!-- *  -->
<!-- **Classification** -->
<!-- *  -->
<!-- **Sign and Symptom** -->
<!-- *  -->
<!-- **Association** -->
<!-- *  -->
<!-- **Examination** -->
<!-- *  -->
<!-- **Diagnosis** -->
<!-- *  -->
<!-- **Treatment** -->
<!-- *  -->
<!-- **Prognosis** -->
<!-- *  -->
<!-- **Appendix** -->
<!-- *  -->

## Budd-Chiari

**Definition**

[![][img_Budd-Chiari]][img_Budd-Chiari]

* IVCの閉塞

<!-- **Etiology** -->
<!-- *  -->
<!-- **Epidemiology** -->
<!-- *  -->
<!-- **Classification** -->
<!-- *  -->
<!-- **Sign and Symptom** -->
<!-- *  -->
<!-- **Association** -->
<!-- *  -->
<!-- **Examination** -->
<!-- *  -->
<!-- **Diagnosis** -->
<!-- *  -->
<!-- **Treatment** -->
<!-- *  -->
<!-- **Prognosis** -->
<!-- *  -->
<!-- **Appendix** -->
<!-- *  -->

##

<!-- ## -->
<!-- <h6 id='-def'>Definition</h6> -->
<!-- <h6 id='-eti'>Etiology</h6> -->
<!-- <h6 id='-epi'>Epidemiology</h6> -->
<!-- <h6 id='-cls'>Classification</h6> -->
<!-- <h6 id='-sx'>Sign and Symptom</h6> -->
<!-- <h6 id='-cmp'>Complication</h6> -->
<!-- <h6 id='-ex'>Examination</h6> -->
<!-- <h6 id='-dx'>Diagnosis</h6> -->
<!-- <h6 id='-tx'>Treatment</h6> -->
<!-- <h6 id='-prg'>Prognosis</h6> -->
<!-- <h6 id='-app'>Appendix</h6> -->

[img_Budd-Chiari]: ../img/b_Hepa/Budd-Chiari.jpg

<!--
<style type="text/css">
	img{width: 50%; float: right;}
</style>
-->